Evaluating the contribution of the cause of kidney disease to prognosis in ckd: Results from the Study of Heart and Renal Protection (SHARP)

American Journal of Kidney Diseases

Volumn 64, Issue 1, 2014, Pages 40-48

  Haynes, Richard ^a   Staplin, Natalie ^a   Emberson, Jonathan ^a   G Herrington, William ^a   Tomson, Charles ^b   Agodoa, Lawrence ^c   Tesar, Vladimir ^d   Levin, Adeera ^e   Lewis, David ^a   Reith, Christina ^a   Baigent, Colin ^a   Landray, Martin J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NORTH BRISTOL NHS TRUST   (United Kingdom)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d CHARLES UNIVERSITY   (Czech Republic)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

cystic kidney disease; disease progression; disease trajectory; end stage renal disease (ESRD); Index Words; Kidney disease etiology; prognosis; risk factor

Indexed keywords

EZETIMIBE; PLACEBO; SIMVASTATIN;

ADULT; AGED; ALBUMINURIA; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OBSERVATIONAL STUDY; PROGNOSIS; RENAL REPLACEMENT THERAPY; STUDY OF HEART AND RENAL PROTECTION;

CYSTIC KIDNEY DISEASE; DISEASE PROGRESSION; DISEASE TRAJECTORY; END-STAGE RENAL DISEASE (ESRD); KIDNEY DISEASE ETIOLOGY; PROGNOSIS; RISK FACTOR;

AGED; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS; HUMANS; KIDNEY DISEASES, CYSTIC; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SURVIVAL RATE;

EID: 84903271292     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2013.12.013     Document Type: Article

References (22)

1. A.S. Levey, and J. Coresh Chronic kidney disease Lancet 379 9811 2012 165 180
2. K. Matsushita, M. van der Velde, and B.C. Astor et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis Lancet 375 9731 2010 2073 2081
3. B.R. Hemmelgarn, B.J. Manns, and A. Lloyd et al. Relation between kidney function, proteinuria, and adverse outcomes JAMA 303 5 2010 423 429
4. R.T. Gansevoort, K. Matsushita, and M. van der Velde et al. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts Kidney Int 80 1 2011 93 104
5. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease Kidney Int Suppl 3 2012 1 150
6. P. Jungers, T. Hannedouche, Y. Itakura, G. Albouze, B. Descamps-Latscha, and N.K. Man Progression rate to end-stage renal failure in non-diabetic kidney diseases: a multivariate analysis of determinant factors Nephrol Dial Transplant 10 8 1995 1353 1360
7. D.B. Jovanovic, and L. Djukanovic Analysis of factors influencing chronic renal failure progression Ren Fail 21 2 1999 177 187
8. J.P. Wight, S. Salzano, C.B. Brown, and A.M. el Nahas Natural history of chronic renal failure: a reappraisal Nephrol Dial Transplant 7 5 1992 379 383
9. P.S. Williams, G. Fass, and J.M. Bone Renal pathology and proteinuria determine progression in untreated mild/moderate chronic renal failure Q J Med 67 252 1988 343 354
10. L.G. Hunsicker, S. Adler, and A. Caggiula et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study Kidney Int 51 6 1997 1908 1919
11. M.E. Grams, J. Coresh, D.L. Segev, L.M. Kucirka, H. Tighiouart, and M.J. Sarnak Vascular disease, ESRD, and death: interpreting competing risk analyses Clin J Am Soc Nephrol 7 10 2012 1606 1614
12. T. Greene, J.J. Bourgoignie, and V. Habwe et al. Baseline characteristics in the Modification of Diet in Renal Disease Study J Am Soc Nephrol 4 5 1993 1221 1236
13. C. Baigent, M.J. Landray, and C. Reith et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial Lancet 377 9784 2011 2181 2192
14. SHARP Collaborative Group Study of Heart and Renal Protection (SHARP): randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease Am Heart J 160 5 2010 785 794.e10
15. A.S. Levey, T. Greene, J.W. Kusek, G.J. Beck MDRD Study Group A simplified equation to predict glomerular filtration rate from serum creatinine [abstract A0828] J Am Soc Nephrol 11 2000 155A
16. D.R. Cox Regression models and life-tables J R Stat Soc B 34 2 1972 187 220
17. J.D. Kalbfleisch, and R.L. Prentice The Statistical Analysis of Failure Time Data 1980 John Wiley & Sons New York, NY
18. J.P. Fine, and R.J. Gray A proportional hazards model for the subdistribution of a competing risk J Am Stat Assoc 94 1999 496 509
19. M. Plummer Improved estimates of floating absolute risk Stat Med 23 1 2004 93 104
20. SHARP Collaborative Group. Effects of lowering LDL cholesterol on progression of kidney disease. J Am Soc Nephrol. in press.
21. B.M. Brenner, M.E. Cooper, and D. de Zeeuw et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy N Engl J Med 345 12 2001 861 869
22. E.J. Lewis, L.G. Hunsicker, and W.R. Clarke et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes N Engl J Med 345 12 2001 851 860